GGHC
CELG

Gilder Gagnon Howe & Co’s Celgene Corp CELG Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-2,546
Closed -$215K – 302
2013
Q4 		$215K Sell
2,546
-3,446
-58% -$273K ﹤0.01% 239
2013
Q3 		$462K Hold
5,992
– – 0.01% 224
2013
Q2 		$350K Buy
+5,992
New +$361K 0.01% 241

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Gilder Gagnon Howe & Co's CELG Position: Q1 2014 in Review

Gilder Gagnon Howe & Co sold out of Celgene Corp (CELG) in Q1 2014, closing a stake of 2,546 shares — an estimated $215K sold.

Gilder Gagnon Howe & Co first reported a position in CELG in Q2 2013 and held it in 3 quarters. The position peaked at $462K in Q3 2013. 980 funds tracked by Wall St. Rank hold CELG as of Q1 2014.

  • Gilder Gagnon Howe & Co reported no remaining Celgene Corp position as of Q1 2014 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 2,546 Celgene Corp shares in Q1 2014, an estimated $215K.
  • Gilder Gagnon Howe & Co first reported a position in Celgene Corp in Q2 2013 and held it in 3 quarters.
  • Gilder Gagnon Howe & Co's Celgene Corp position peaked at $462K in Q3 2013.
  • 980 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2014.

Based on Gilder Gagnon Howe & Co's 13F filing for Q1 2014, filed 9 May 2014.